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ABSTRACT 
Objective: To develop and validate a novel, specific, precise and simple UV-spectrophotometric method for the estimation of lornoxicam present in 
microsponges. 
Methods: UV-spectrophotometric determination was performed with Thermo Scientific Evolution 201 UV-Vis spectrophotometer using methanol 
as a medium. The spectrum of the standard solution was run from 200-400 nm range for the determination of absorption maximum (λ max). λ max 
of lornoxicam was found at 353 nm. The absorbance of standard solutions of 3, 6, 9, 12 and 15, µg/ml of drug solution was measured at an 
absorption maximum at 353 nm against the blank. Then a graph was plotted by taking concentration on X-axis and absorbance on Y-axis which gave 
a straight line. Validation parameters such as linearity and range, selectivity and specificity, LOD and LOQ, accuracy, precision and robustness
Results: Linearity for the UV-spectrophotometric method was noted over a concentration range of 3.0-15.0 µg/ml with a correlation coefficient of 
0.9995. The limit of detection (LOD) and limit of quantification (LOQ) for lornoxicam was found at 1.26 μg/ml and 3.82 μg/ml respectively. Accuracy 
was in between 
 were 
evaluated as per ICH guidelines.  
99.21 and 99.60%. 
Conclusion: The proposed UV-Visible spectrophotometric method was validated according to the ICH guidelines and results and statistical parameters 
demonstrated that the developed method is sensitive, precise, reliable and simple for the estimation of lornoxicam present in microsponges.  
% RSD for repeatability, intraday precision and interday precision were found to be 0.473, in between 0.478 and 
0.619 and in between 0.855 and 1.818 respectively. The proposed UV method is found to be robust. 
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Lornoxicam is a new NSAID belonging to the oxicam class. It is a 
strong analgesic and anti-inflammatory NSAID as compared to other 
NSAIDs. Chemically its 6-chloro-4-hydroxy-2-methyl-N-2-pyridyl-
2H-thieno-[2, 3-e]-1,2-Thiazine-3-carboxamide-1,1-dioxide. Like all 
NSAIDs, it is also having anti-inflammatory and antipyretic (fever 
reducing) properties [1]. It is available in oral and parenteral 
formulations. Lornoxicam is a yellow or slightly yellow powder [2]. 
It is slightly soluble in water, soluble in methanol, ethanol and 
isopropyl alcohol [3]. 
In the treatment of osteoarthritis and rheumatoid arthritis, 
lornoxicam is given by mouth in a daily dose of 12 mg in two or 
three divided doses. Lornoxicam is given in doses of 8-16 mg daily 
by mouth for the treatment of pain. Similar doses may be given by 
intravenous or intramuscular injection, although in rare cases the 
maximum initial daily dose may be increased to 24 mg; treatment by 
injection should be limited to two days [4]. 
Lornoxicam is a non-selective inhibitor of the enzyme cyclo-
oxygenase, inhibiting both the cyclooxygenase-1 (COX-1) and 
cyclooxygenase-2 (COX-2) isoenzymes. Cyclooxygenase catalyzes the 
formation of prostaglandins and thromboxane from arachidonic 
acid. Prostaglandins act as messenger molecules in the process of 




The literature survey reveals that various analytical methods have 
been developed such as HPLC [7-9], HPTLC [10] and UV spectroscopy 
methods [11-14] for the estimation of lornoxicam present in bulk, 
single or combinational pharmaceutical formulations. Most of the 
reported methods are using several solvents, expensive reagents and 
often time-consuming. Because of simplicity of UV spectrophotometry 
and also precise, reliable, minimum solvent usage and requires less 
analysis time, it is widely used for the estimation of drug content in 
bulk and pharmaceutical products. 
 Chemical structure of lornoxicam 
A detailed review of the literature regarding the existing methods 
revealed that there is a need for the development of the 
spectrophotometric method, which is simple for the estimation of 
lornoxicam present in microsponges. An effort was made in the 
present method to develop a simple, sensitive, accurate, reliable and 
reproducible with minimum Relative Standard Deviation (RSD) 
values for the estimation of lornoxicam present in microsponges.  
MATERIALS AND METHODS 
Materials 
Lornoxicam was procured from Pradeep Kumar pharma Pvt. Ltd 
(Mumbai-India), Eudragit RS 100 and Eudragit RSPO are gifted by 
Evonik Pharma, Mumbai, India. All other chemicals used were of 
analytical reagent grade.  
Equipment used 
Spectroscopic analysis was carried out using thermo scientific 
evolution 201 double beam UV-Visible spectrophotometer with 10 
mm path length quartz cells was used for the analytical purpose. 
Preparation of stock and standard solution for calibration curve 
For the method development, a stock solution of lornoxicam was 
prepared by dissolving 10 mg of the drug in 10 ml of methanol so as 
to obtain a final concentration of 1 mg/ml. From this stock solution, 
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subsequent dilutions were made with methanol to obtain the series 
of standard solutions containing 3, 6, 9, 12 and 15µg/ml of solution. 
The spectrum of the standard solutions was run from 200-400 nm 
range for the determination of absorption maximum (λ max). λ max 
of lornoxicam was found at 353 nm. The absorbance of above 
dilutions was measured at 353 nm by using methanol as a blank. A 
graph was plotted by taking concentration on X-axis and absorbance 
on Y-axis which gave a straight line. 
Analysis of lornoxicam in microsponges 
Microsponges equivalent to 16 mg of pure drug was crushed, 
powdered and was taken in 100 ml volumetric flask. To this 80 ml of 
methanol was added and shaken for 1 h on a mechanical shaker and 
then sonicated for 5 min to complete removal of lornoxicam from 
microsponges. After sonication, volume was made up to the mark 
with methanol. This solution was centrifuged and filtered. Filtered 
sample was suitably diluted and analyzed spectrophotometrically at 
353 nm using the proposed method.  
Validation of developed analytical method 
This developed method for estimation of lornoxicam was validated 
as per ICH guidelines [15-18]. 
Linearity and range 
Linearity is the ability of a method to elicit test results that are 
directly proportional to the analyte concentration within a given 
range. The range is the interval between the upper and lower levels 
of analytes that have been demonstrated to be determined with 
precision, accuracy, and linearity using the method as described. 3, 
6, 9, 12 and 15 µg/ml of standard solutions were selected for 
assessing linearity range. The calibration curve was plotted using 
concentration of the standard solution versus absorbance and the 
regression equation was calculated. The least squares method was 
used to calculate the slope, intercept and correlation coefficient.  
Selectivity and specificity 
The ability to measure accurately and specifically the analyte of 
interest in the presence of other components like excipients, in the 
microsponges was analyzed. Placebo solution was prepared by 
adding polymers like Eudragit RS 100, Eudragit RSPO and 
plasticizers like polyethene glycol and propylene glycol to methanol. 
The standard, placebo, placebo along with analyte and test 
preparations were analyzed as per the method to identify 
interference of placebo with the absorbance of lornoxicam.  
Detection and quantification limits 
Limit of detection (LOD) represents the lowest amount of analyte in 
the sample which can be detected. Limit of quantification (LOQ) 
represents the lowest amount of analyte, which can be quantitatively 
determined. LOD and LOQ are calculated based on the standard 
deviation of the response and the slope of the calibration curve.  
LOD = 3.3σ/S  
LOQ = 10σ/S 
Accuracy 
The accuracy of the proposed method was assessed by recovery 
studies at three different levels i.e., 80%, 100% and 120%. The 
recovery studies were carried out by adding a known amount of 
standard solution of lornoxicam to a pre-analyzed microsponge 
solution. 
Precision  
The resulting solutions were then re-analyzed by the 
proposed method. The total amount of drug found and percentage 
recovery was calculated. 
The precision of the method was performed at three different levels: 
repeatability, intra-day precision and inter-day precision at three 
different concentration levels of analyte covering the concentration 
range. In repeatability, the absorbance of the 6 µg/ml 
lornoxicam concentration solution was measured six times and % 
RSD was calculated. The intra-day precision was performed by 
analyzing six replicate standard solutions on the same day, and 
inter-day precision was performed by analyzing a series of standard 
solutions for 3 consecutive days using the proposed UV-
spectrophotometric method.  
Robustness 
RESULTS AND DISCUSSION  
The evaluation of robustness should be considered during the 
development phase and depends on the type of procedure deliberate 
variations in method parameters. If measurements are susceptible 
to variation in analytical conditions, the analytical condition should 
be suitably controlled or a precautionary statement should be 
included in the procedure. In this present work absorption maxima 
was decreased and increased by 1 nm and the process was carried 
for 9 μg/ml standard solution. The % RSD was calculated. 
The proposed method was found to be simple, sensitive, accurate, 
precise, economical and rapid for the estimation of lornoxicam in 
microsponges. The method was validated as per ICH guidelines (Q2 (R1). 
Linearity and range  
A linear correlation was found between absorbance at λmax and 
concentration of lornoxicam. The graph is described by the 
regression equation: Y= a+bX (where Y=absorbance of drug 
solution; a =intercept; b =slope and X=concentration of drug 
in μg/ml
 
). The slope (b), intercept (a) and correlation coefficient (r) 
were evaluated by using the method of least squares. Good linear 
correlations were obtained between absorbance and standard drug 
concentration in the selected range of 3.0-15.0 μg/ml. Characteristic 
parameters such as slope is 0.0538, the intercept is 0.0059, and the 
correlation coefficient is 0.9995. 
Table 1: Calibration curve of lornoxicam in methanol 






 *SD-standard deviation 
 
Specificity in the presence of polymers and plasticizers 
The selectivity and specificity of the proposed method were tested 
by studying the effect of various polymers and plasticizers used in 
the preparation of microsponges. In the analysis of placebo, the 
absorbance value was nearly the same as that for solvent suggesting 
the non-interference by the inactive ingredients added to prepare 
the placebo solution.  
Limit of detection (LOD) and limit of quantification (LOQ) 
The LOD and LOQ of lornoxicam were determined by using the 
standard deviation of the response and slope approach as defined in 
International Conference on Harmonization (ICH) guidelines. The limit 
of detection (LOD) and limit of quantification (LOQ) for lornoxicam 
were found to be 1.26 μg/ml and 3.82 μg/ml respectively, indicating 
that the proposed UV method is highly sensitive. Results of regression 
and analytical parameters are reported in table 2. 
Prasad et al. 




Fig. 2: Calibration curve of lornoxicam in methanol 
 
Table 2: Regression and analytical parameters 
Parameter Value 
λmax, 353 nm 
Beer’s law limits (μg/ml) 3-15 
Regression equation, Y * Y = 0.0538X+0.0061 
Intercept, (a) 0.0061 
Slope, (b) 0.0538 
Correlation coefficient (r) 0.9995 
Standard deviation of intercept 0.020566 
Limit of detection (μg/ml) 1.26 
Limit of quantification (μg/ml)  3.82 
*Y=a+bX, where Y is the absorbance, a is the intercept, b is the slope and X is the concentration in μg/ml. 
 
Accuracy 
The accuracy of an analytical method is the closeness of test results 
to a true value. The accuracy of the method was evaluated by 
standard addition method at 3 levels. A standard quantity equivalent 
to 80%, 100% and 120% is to be added to the sample. Results within 
the range of 99.21-99.60% ensure an accurate method as well as 
indicate of non-interference with the excipients.  
 
Results of recovery studies are reported in table 3. 
Table 3: Accuracy/recovery studies for three different concentrations of lornoxicam by the proposed method 










80 7.2 7.14 99.17 99.21±0.347 0.350 
80 7.2 7.12 98.89 
80 7.2 7.17 99.58 
100 9 8.91 99.00 99.40±0.357 0.359 
100 9 8.96 99.55 
100 9 8.97 99.67 
120 10.8 10.74 99.45 99.60±0.189 0.190 
120 10.8 10.75 99.53 
120 10.8 10.78 99.81 
 *SD-standard deviation, RSD**-relative standard deviation 
 
Precision 
% RSD for repeatability, intraday precision and interday precision 
were found to be 0.473, in between 0.478 and 0.619 and in between 
0.855 and 1.818 respectively. The results showed an excellent 
repeatability, intra-day precision and inter-day precision of the 




Table 4: Repeatability studies 
Concentration (μg/ml Absorbance ) Mean±SD* (n=3) % RSD** 






*SD-standard deviation, RSD**-relative standard deviation 
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Table 5: Intra-day precision for five different concentrations of lornoxicam 
Concentration (μg/ml Time ) % RSD** 
10:30 a. m. 1:00 p. m. 4:30 p. m. 
3 0.168 0.167 0.166 0.599 
6 0.321 0.319 0.318 0.478 
9 0.503 0.501 0.499 0.601 
12 0.650 0.647 0.645 0.619 
15 0.811 0.808 0.805 0.496 
 RSD**-relative standard deviation, 
 
Table 6: Inter-day precision for five different concentrations of lornoxicam 
Concentration (μg/ml Day ) % RSD** 
1 2 3 
3 0.168 0.165 0.162 1.818 
6 0.321 0.315 0.311 1.594 
9 0.503 0.497 0.492 1.107 
12 0.650 0.644 0.639 0.855 
15 0.811 0.802 0.796 0.940 
 RSD**-relative standard deviation, 
 
Robustness 
The robustness of this method was tested in terms of variation in 
wavelength change. Experimental findings proved that the change 
since % RSD values was found to be less than 0.9% (less than the 
acceptable theoretical limit of<2% RSD). The proposed UV method 
was found to be robust. The results obtained were presented in 
table 7. 
  
Table 7: Effect of different wavelengths of light on a 9 µg/ml
Wavelength 









352 9 0.499 0.501±0.001 0.305 
0.501 
0.502 
353 9 0.503 0.503±0.001 0.304 
0.501 
0.504 
354 9 0.498 0.500±0.002 0.416 
0.499 
0.502 
 *SD-standard deviation, RSD**-relative standard deviation 
 
CONCLUSION 
This developed method is found to be specific as there was no 
interference of any excipients present microsponges in the analysis 
of lornoxicam. The results and the statistical parameters 
demonstrated that the proposed UV spectrophotometric method is 
simple, rapid, reliable, accurate and precise. Hence, it can be used 
conveniently for the determination of drug entrapped in micro-
sponges. 
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